DPD has been proposed as a therapeutic target for interferon-α (IFN-α) treatment, which is effective in some HCC patients in reducing metastasis by inhibition of epithelial-mesenchymal transition (EMT) through DPD down-regulation. This evidence concerns the gene DPYD and hepatocellular carcinoma.